CINECA IRIS Institutional Research Information System

BELLINI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.595
EU - Europa 3.398
AS - Asia 1.118
AF - Africa 152
OC - Oceania 18
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.398
IT - Italia 1.364
SE - Svezia 651
CN - Cina 561
BG - Bulgaria 363
DE - Germania 269
GB - Regno Unito 216
CA - Canada 187
VN - Vietnam 184
SG - Singapore 180
UA - Ucraina 142
CI - Costa d'Avorio 93
TR - Turchia 88
FI - Finlandia 85
AT - Austria 73
CH - Svizzera 61
HK - Hong Kong 50
RU - Federazione Russa 37
FR - Francia 30
NG - Nigeria 29
IN - India 23
NL - Olanda 22
SN - Senegal 21
ES - Italia 19
PL - Polonia 19
AU - Australia 16
BE - Belgio 16
MX - Messico 10
NO - Norvegia 10
BR - Brasile 9
EG - Egitto 9
IR - Iran 7
GR - Grecia 6
AE - Emirati Arabi Uniti 4
EU - Europa 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
MY - Malesia 3
PH - Filippine 3
DK - Danimarca 2
IL - Israele 2
JP - Giappone 2
KR - Corea 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
HU - Ungheria 1
ID - Indonesia 1
IE - Irlanda 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 12.300
Salva come PNG Salva come JPEG
Città #
Fairfield 953
Woodbridge 756
Houston 633
Ann Arbor 590
Serra 580
Ashburn 541
Chandler 529
Seattle 404
Sofia 363
Cambridge 349
Wilmington 342
New York 250
Beijing 206
Milan 196
Boulder 190
Jacksonville 182
Ottawa 174
Princeton 173
Lawrence 156
Medford 134
Nanjing 103
Abidjan 93
Des Moines 86
Izmir 85
London 85
Dearborn 78
Dong Ket 71
Vienna 68
Florence 63
Bern 56
Hong Kong 50
San Diego 48
Nanchang 41
Pisa 38
Kunming 36
Jüchen 33
Washington 32
Bremen 31
Lagos 29
Shenyang 26
Redwood City 25
Rome 25
Dakar 21
Norwalk 19
Changsha 17
Hebei 17
Tianjin 17
Brussels 16
Falls Church 16
Hefei 15
Massa 13
Ogden 13
Phoenix 13
Redmond 12
Verona 12
Jinan 11
Kent 11
Livorno 11
Lucca 11
Guangzhou 10
Singapore 10
Frankfurt am Main 9
Jiaxing 9
Los Angeles 9
Orange 9
Carrara 8
Council Bluffs 8
Groningen 8
Lancaster 8
Amsterdam 7
Auburn Hills 7
Cairo 7
Pune 7
Bergen 6
Chicago 6
Toronto 6
Warsaw 6
Ypsilanti 6
Boardman 5
Castelnovo di Sotto 5
Hangzhou 5
Lanzhou 5
Poitiers 5
San Francisco 5
Bari 4
Catania 4
Dallas 4
Dubai 4
Helsinki 4
Marseille 4
Melbourne 4
Mountain View 4
Renton 4
Shanghai 4
São Paulo 4
Assisi 3
Bethesda 3
Bones 3
Canberra 3
Cascina 3
Totale 9.383
Salva come PNG Salva come JPEG
Nome #
Evaluation of Pancreatic Exocrine Function in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas 270
Management of Chronic constipation in general practice 178
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? 160
Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett’s oesophagus for 1 year 155
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics 153
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 153
Lactobacillus Casei DG® in Patients with Irritable Bowel Syndrome: Not Only a Change of the Gut Microbiota. A Pilot Study 142
Role of faecal calprotectin as non-invasive marker of intestinal inflammation 139
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 139
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 138
null 136
The general practitioner's approach to irritable bowel syndrome: from intention to practice 136
Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron 135
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 134
Radionuclide evaluation of the lower gastrointestinal tract 132
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome 131
Thrombocytopenic purpura: an unusual complication of eradication therapy for Helicobacter pylori 129
Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? 125
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy 122
Famotidine in the short-term treatment of duodenal ulcer and of concomitant peptic lesions : comparison with cimetidina 122
The daily diary and the questionnaire are not equivalent for the evaluation of bowel habits 119
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 119
Subthreshold psychiatric psychopathology in Functional gastrointestinal disorders: Can it be the bridge between gastroenterology and psychiatry? 116
Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease 114
Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole 113
Association between baseline impedance values and response proton pump inhibitors in patients with heartburn 113
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 112
Gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome: Common overlapping gastrointestinal disorders 111
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 110
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? 110
White Paper of Italian Gastroenterology: Delivery of services for digestive diseases in Italy: Weaknesses and strengths 109
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome 107
Liver triglyceride accumulation after chronic ethanol administration: a possible protective role of metadoxina and ubiquinon 105
Pros and Cons of the SeHCAT Test in Bile Acid Diarrhea: A More Appropriate Use of an Old Nuclear Medicine Technique 105
Esophageal testing: What we have so far 104
Alcohol and women: a study in high schools 103
Gastric emptying in myotonic dystrophic patients. 103
Irritable bowel syndrome and chronic constipation: Fact and fiction 101
Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure 101
Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation 100
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. 100
Pelvic floor dyssynergia and psychiatric disorders. Does the snake bite its tail? 96
Gastrointestinal manifestations in myotonic muscular dystrophy 96
Evaluation of latent links between irritable bowel syndrome and sleep quality 95
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study 94
Bioelectrical impedance vector analysis in patients with irritable bowel syndrome on a low FODMAP diet: a pilot study 93
A new psychiatric assessment of patients affected with functional gastrointestinal diseases. 92
Can psychiatric evaluation be useful in patients affected with pelvic floor dyssynergia? 92
The general practitioner's management of patients with a new diagnosis of irritable bowel syndrome 92
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 92
Optimal treatment of laryngopharyngeal reflux disease 92
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 90
Chronic constipation diagnosis and treatment evaluation: The "CHRO.CO.DI.T.E." study 90
Post-traumatic inflammatory pseudotumor of the esophagus 89
Diagnosi e follow-up ecografici di un ematoma splenico 87
Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD 86
An extended assessment of bowel habits in a general population 86
Pelvic floor rehabilitation for defecation disorders 85
Alterazioni della motilità colecistica nella distrofia miotonica: valutazione mediante ecotomografia funzionale 84
Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome 84
I farmaci citoprotettivi 83
Gallbladder motility following intake of mineral bicarbonate-alkaline water. Ultrasonographic assessement 83
Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD 81
Velusetrag for the treatment of chronic constipation 80
Relationship of TT virus and Helicobacter pilori infections in gastric tissues of patients with gastritis 79
Double pylorus: report of two cases and review of the literature 77
Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement 77
13C-octanoic acid breath test (OBT) with a new test meal (EXPIROGer®): Toward standardization for testing gastric emptying of solids 76
Serum gamma-glutamyl-transpeptidase isoforms in alcoholic liver disease 75
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 75
High Resolution and High Definition Anorectal Manometry 75
Comorbidities in functional gastrointestinal diseases: Do we need a lone ranger or a dream team? 74
Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (Part II: Treatment) 74
Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation 74
Can the gamma-glutamyl transpeptidase isoforms really be utilized in the diagnosis of alcoholic liver disease? (multiple letters) [1] 73
Plecanatide for the treatment of chronic idiopathic constipation in adult patients 73
Is a low FODMAP diet dangerous? 72
Platelet serotonin transporter in diarrhoea predominant irritable bowel syndrome. 71
Duloxetine in panic disorder with somatic gastric pain 71
Consensus statement AIGO/SICCR: Diagnosis and treatment of chronic constipation and obstructed defecation (part I: Diagnosis) 71
Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: The top-down and the bottom-up model 69
IBS clinical management in Italy: The AIGO survey 69
Simulation of real-time deformable soft tissues for computer assisted surgery 69
Loss-of-function of the voltage-gated sodium channel NaV1.5 (Channelopathies) in patients with irritable bowel syndrome 69
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 69
The genetics of human serotonin transporter and irritable bowel syndrome 68
Randomised controlled trial of mesalazine in IBS 68
Low FODMAP diet: Evidence, doubts, and hopes 68
Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection. 67
The use of prucalopride in real life for the treatment of constipation subtypes: Ups and downs 67
Bile reflux in patients with nerd is associated with more severe heartburn and lower values of mean nocturnal baseline impedance and chemical clearance 67
Gastroprotezione durante chemioterapia antitumorale: esperienza con farmaci antisecretivi 66
Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome 66
Different perception of chronic constipation between patients and gastroenterologists 66
Digital Rectal Examination: The Whole World is a Country! 66
Self-perceived normality in defecation habits 66
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio 66
Radionuclide Gastroesophageal Motor Studies 66
Therapeutic Approach for Irritable Bowel Syndrome: Old and New Strategies 65
Constipation severity is associated with productivity losses and healthcare utilization in patients with chronic constipation 65
Totale 9.775
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.909
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019634 0 0 0 0 0 0 0 0 0 0 365 269
2019/20203.131 345 267 660 199 254 286 265 195 250 148 211 51
2020/20211.300 97 56 97 124 102 64 130 80 117 109 75 249
2021/20221.646 19 71 29 96 298 233 77 107 90 50 112 464
2022/20232.001 248 271 182 132 202 257 25 168 334 7 154 21
2023/20241.467 192 133 235 101 209 350 105 54 43 33 12 0
Totale 12.679